<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pmj-1870</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТОДИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>METHODS</subject></subj-group></article-categories><title-group><article-title>Оптимизация введения противоопухолевых лекарственных средств</article-title><trans-title-group xml:lang="en"><trans-title>OPTIMIZATION OF ANTICANCER DRUGS INTRODUCTION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буйденок</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Buydenok</surname><given-names>Yu. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мещеряков</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mescheryakov</surname><given-names>A. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский онкологический научный центр им. Н.Н. Блохина РАМН (г. Москва)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.N. Blokhin Russian Oncologic Research Centre (Moscow)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2004</year></pub-date><volume>0</volume><issue>4</issue><fpage>78</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Буйденок Ю.В., Мещеряков А.А., 2004</copyright-statement><copyright-year>2004</copyright-year><copyright-holder xml:lang="ru">Буйденок Ю.В., Мещеряков А.А.</copyright-holder><copyright-holder xml:lang="en">Buydenok Y.V., Mescheryakov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/1870">https://www.tmj-vgmu.ru/jour/article/view/1870</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>Modern chemotherapy is impracticable without due maintenance of oncological patients' life quality. New modes of cytostatic drug introduction allow undergoing almost any courses of medical treatment on an outpatient basis, while long-term chemotherapy and anaesthesia are performed by using specially developed infusion systems. Subcutaneous implantation of ports that are devices for multiple infusions makes for easier introducing of medicinal agents, thus avoiding extravasation and phlebitis. The authors share their own experience in using outpatient infusion pumps and ports.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>онкологические больные</kwd><kwd>качество жизни</kwd><kwd>устройства для инфузий</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Clamon G.H. // The chemotherapy source book. 2nd ed. — Baltimore: Wlliams &amp; Wilkins, 1996. - P. 607-611.</mixed-citation><mixed-citation xml:lang="en">Clamon G.H. // The chemotherapy source book. 2nd ed. — Baltimore: Wlliams &amp; Wilkins, 1996. - P. 607-611.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rudolph R., Larson D.L. // Journal Clin. Oncol. — 1987. - Vol. 5. - P. 1116-1126.</mixed-citation><mixed-citation xml:lang="en">Rudolph R., Larson D.L. // Journal Clin. Oncol. — 1987. - Vol. 5. - P. 1116-1126.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
